Search company, investor...

Power Medical Interventions

Founded Year



Series C | Alive

Total Raised


Last Raised

$14.5M | 17 yrs ago

About Power Medical Interventions

Power Medical Interventions (PMI) is a medical device company headquartered in Langhorne, Pennsylvania. Founded in 2000, PMI was formed for the purpose of designing, developing, and marketing new computerized and reusable devices and methods for delivering staples during surgery. This forms the basis of their SurgASSIST System which is a computer-mediated transection and anastomosis device.

Headquarters Location

2021 Cabot Boulevard West

Langhorne, Pennsylvania, 19047,

United States


Missing: Power Medical Interventions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Power Medical Interventions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Power Medical Interventions Patents

Power Medical Interventions has filed 9 patents.

patents chart

Application Date

Grant Date


Related Topics




Device drivers, Video cards, Linux drivers, Video acceleration, Graphics processing units


Application Date


Grant Date



Related Topics

Device drivers, Video cards, Linux drivers, Video acceleration, Graphics processing units



Power Medical Interventions Frequently Asked Questions (FAQ)

  • When was Power Medical Interventions founded?

    Power Medical Interventions was founded in 1999.

  • Where is Power Medical Interventions's headquarters?

    Power Medical Interventions's headquarters is located at 2021 Cabot Boulevard West, Langhorne.

  • What is Power Medical Interventions's latest funding round?

    Power Medical Interventions's latest funding round is Series C.

  • How much did Power Medical Interventions raise?

    Power Medical Interventions raised a total of $63.5M.

  • Who are the investors of Power Medical Interventions?

    Investors of Power Medical Interventions include Hercules Capital, NGN Capital and Koch Genesis Company.

  • Who are Power Medical Interventions's competitors?

    Competitors of Power Medical Interventions include ReShape Medical, FloShield, Ocular Therapeutix, MiCardia, Interventional Spine and 10 more.

Compare Power Medical Interventions to Competitors

Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.


NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.


FloShield is a family of products that improve visualization during laparoscopic surgery. It was founded in 2009 and is based in Cupertino, California.

OrthAlign Logo

OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.


Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.

CSA Medical Logo
CSA Medical

CSA Medical is a developer of cryospray therapy platforms, truFreeze, and Rejuvenair.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.